Zioptan Ophthalmic Drops, Solution 0.0015pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

ZIOPTAN: Ophthalmic drops, solution (0.0015%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
ZIOPTAN Ophthalmic Solution
Drug Image file default-drug-image.png
ZIOPTAN Ophthalmic Solution

What is this Medicine?

TAFLUPROST (ta FLU prost) is used in the eye to treat open-angle glaucoma and high pressure in the eye.

CVS Pharmacy Patient Statistics for ZIOPTAN: Ophthalmic drops, solution(0.0015%)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

ZIOPTAN 0.0015% Ophthalmic Solution

NDC: 000063931
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Glaucoma, Increased Intraocular Pressure, Ocular Hypertension

Storage Information
Refrigerate (between 36 and 46 degrees F)
Product may be stored in the opened foil pouch for up to 28 days at room temperature (68 to 77 degrees F)
Discard unused product 28 days after first opening the pouch
Store in original container
Protect from moisture
ZIOPTAN 0.0015% Ophthalmic Solution

Reported Side Effects for ZIOPTAN 0.0015% Ophthalmic Solution

Blurred Vision Incidence:
2.0%*
Severity: MODERATE
Onset: EARLY
Infection Incidence:
2.0-4.0%*
Severity: MILD
Onset: DELAYED
Cataracts Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Dry Eyes Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Eye Pain Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Cough Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Red Eyes Incidence:
4.0-20.0%*
Severity: MODERATE
Onset: EARLY
Itchy Eyes Incidence:
5.0%*
Severity: MILD
Onset: RAPID
Headache Incidence:
6.0%*
Severity: MILD
Onset: EARLY
Eye Irritation Incidence:
7.0%*
Severity: MILD
Onset: RAPID
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with ZIOPTAN

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.